Rajiv R. RATAN,Saravanan KARUPPAGOUNDER,Thomas I. BRADSHAW
申请号：
US15968355
公开号：
US20180344678A1
申请日:
2018.05.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.
